Coccidioidomycosis and the indications for chemotherapy

Molecular epidemiology of global Candida dubliniensis isolates utilizing genomic-wide, co-dominant, PCR-based markers for strain delineation.

Medical mycology·2009

Conventional or molecular measurement of Aspergillus load.

Medical mycology·2008

Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Clinical and experimental immunology·2006

Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.

Medical mycology·2005

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

Medical mycology·2005

Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).

Journal of veterinary pharmacology and therapeutics·2005

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Drugs·2026

Baxdrostat: First Approval.

Drugs·2026

Alopecia Areata: Current and Emerging Therapies.

Drugs·2026

Andamertinib: First Approval.

Drugs·2026

Cefepime/Zidebactam: First Approval.

Drugs·2026

Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.

Drugs·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Research square·2026

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

European journal of pharmacology·2026

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Cancer treatment and research communications·2026

Related Experiment Videos

Coccidioidomycosis and the indications for chemotherapy

Related Concept Videos

Molecular epidemiology of global Candida dubliniensis isolates utilizing genomic-wide, co-dominant, PCR-based markers for strain delineation.

Conventional or molecular measurement of Aspergillus load.

Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Baxdrostat: First Approval.

Alopecia Areata: Current and Emerging Therapies.

Andamertinib: First Approval.

Cefepime/Zidebactam: First Approval.

Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Related Experiment Videos

Coccidioidomycosis and the indications for chemotherapy

Related Concept Videos

Related Articles